Early Factors Associated With Fluid Sequestration and Outcomes of Patients With Acute Pancreatitis

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 6, 2014, Pages 997-1002

  De Madaria, Enrique ^a   Banks, Peter A ^b   Moya Hoyo, Neftalí ^a   Wu, Bechien U ^b,c   Rey Riveiro, Mónica ^a   Acevedo Piedra, Nelly G ^a   Martínez, Juan ^a   Lluís, Félix ^a   Sánchez Payá, José ^a   Singh, Vikesh K ^b,d  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Intravenous fluid therapy; Management; Morbidity; Pancreatic inflammation; Treatment

Indexed keywords

GLUCOSE;

ACUTE PANCREATITIS; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; EMERGENCY CARE; FEMALE; FLUID SEQUESTRATION; FLUID THERAPY; HEMATOCRIT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PANCREAS NECROSIS; RETROSPECTIVE STUDY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PANCREATITIS, ACUTE NECROTIZING; PATHOLOGY; SPAIN; SURVIVAL; TREATMENT OUTCOME; UNITED STATES; WATER-ELECTROLYTE IMBALANCE;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; BOSTON; COHORT STUDIES; FEMALE; FLUID THERAPY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PANCREATITIS, ACUTE NECROTIZING; RETROSPECTIVE STUDIES; SPAIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WATER-ELECTROLYTE IMBALANCE;

EID: 84901227598     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.10.017     Document Type: Article

References (46)

1. Peery A.F., Dellon E.S., Lund J., et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012, 143:1179-1187.
2. Bai Y., Gao J., Zou D.W., et al. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol 2008, 103:104-110.
3. Petrov M.S., van Santvoort H.C., Besselink M.G., et al. Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials. Ann Surg 2008, 247:250-257.
4. Forsmark C.E., Baillie J. AGA Institute technical review on acute pancreatitis. Gastroenterology 2007, 132:2022-2044.
5. Tenner S. Initial management of acute pancreatitis: critical issues during the first 72 hours. Am J Gastroenterol 2004, 99:2489-2494.
6. Banks P.A., Freeman M.L. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006, 101:2379-2400.
7. Whitcomb D.C. Clinical practice: acute pancreatitis. NEngl J Med 2006, 354:2142-2150.
8. Pandol S.J., Saluja A.K., Imrie C.W., et al. Acute pancreatitis: bench to the bedside. Gastroenterology 2007, 132:1127-1151.
9. Navarro S., Amador J., Arguello L., et al. [Recommendations of the Spanish Biliopancreatic Club for the Treatment of Acute Pancreatitis: Consensus development conference]. Gastroenterol Hepatol 2008, 31:366-387.
10. Freeman M.L., Werner J., van Santvoort H.C., et al. Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas 2012, 41:1176-1194.
11. Tenner S., Baillie J., Dewitt J., et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013, 108:1400-1415.
12. Juvonen P.O., Tenhunen J.J., Heino A.A., et al. Splanchnic tissue perfusion in acute experimental pancreatitis. Scand J Gastroenterol 1999, 34:308-314.
13. Niederau C., Crass R.A., Silver G., et al. Therapeutic regimens in acute experimental hemorrhagic pancreatitis: effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor. Gastroenterology 1988, 95:1648-1657.
14. Baillargeon J.D., Orav J., Ramagopal V., et al. Hemoconcentration as an early risk factor for necrotizing pancreatitis. Am J Gastroenterol 1998, 93:2130-2134.
15. Brown A., Orav J., Banks P.A. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas 2000, 20:367-372.
16. Gan S.I., Romagnuolo J. Admission hematocrit: a simple, useful and early predictor of severe pancreatitis. Dig Dis Sci 2004, 49:1946-1952.
17. Wu B.U., Johannes R.S., Sun X., et al. Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology 2009, 137:129-135.
18. Mao E.Q., Tang Y.Q., Fei J., et al. Fluid therapy for severe acute pancreatitis in acute response stage. Chin Med J (Engl) 2009, 122:169-173.
19. Mao E.Q., Fei J., Peng Y.B., et al. Rapid hemodilution is associated with increased sepsis and mortality among patients with severe acute pancreatitis. Chin Med J (Engl) 2010, 123:1639-1644.
20. Wu B.U., Hwang J.Q., Gardner T.H., et al. Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol 2011, 9:710-717.
21. de-Madaria E., Soler-Sala G., Sanchez-Paya J., et al. Influence of fluid therapy on the prognosis of acute pancreatitis: a prospective cohort study. Am J Gastroenterol 2011, 106:1843-1850.
22. Haydock M.D., Mittal A., Wilms H.R., et al. Fluid therapy in acute pancreatitis: anybody's guess. Ann Surg 2013, 257:182-188.
23. Ranson J.H., Rifkind K.M., Roses D.F., et al. Objective early identification of severe acute pancreatitis. Am J Gastroenterol 1974, 61:443-451.
24. Ke L., Ni H.B., Sun J.K., et al. Risk factors and outcome of intra-abdominal hypertension in patients with severe acute pancreatitis. World J Surg 2012, 36:171-178.
25. Sauven P., Playforth M.J., Evans M., et al. Fluid sequestration: an early indicator of mortality in acute pancreatitis. Br J Surg 1986, 73:799-800.
26. Cox P. Insensible water loss and its assessment in adult patients: a review. Acta Anaesthesiol Scand 1987, 31:771-776.
27. Lamke L.O., Nilsson G., Reithner L. The influence of elevated body temperature on skin perspiration. Acta Chir Scand 1980, 146:81-84.
28. Trikudanathan G., Navaneethan U., Vege S.S. Current controversies in fluid resuscitation in acute pancreatitis: a systematic review. Pancreas 2012, 41:827-834.
29. de-Madaria E., Martinez J., Perez-Mateo M. The dynamic nature of fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol 2012, 10:95-96.
30. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995, 273:117-123.
31. Bradley E.L. Aclinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993, 128:586-590.
32. Marshall J.C., Cook D.J., Christou N.V., et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638-1652.
33. Johnson C.D., Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004, 53:1340-1344.
34. Lankisch P.G., Assmus C., Pflichthofer D., et al. Which etiology causes the most severe acute pancreatitis?. Int J Pancreatol 1999, 26:55-57.
35. Papachristou G.I., Papachristou D.J., Morinville V.D., et al. Chronic alcohol consumption is a major risk factor for pancreatic necrosis in acute pancreatitis. Am J Gastroenterol 2006, 101:2605-2610.
36. Brown A., Baillargeon J.D., Hughes M.D., et al. Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis?. Pancreatology 2002, 2:104-107.
37. Lankisch P.G., Blum T., Bruns A., et al. Has blood glucose level measured on admission to hospital in a patient with acute pancreatitis any prognostic value?. Pancreatology 2001, 1:224-229.
38. Rajaratnam S.G., Martin I.G. Admission serum glucose level: an accurate predictor of outcome in gallstone pancreatitis. Pancreas 2006, 33:27-30.
39. Singh V.K., Wu B.U., Bollen T.L., et al. Early systemic inflammatory response syndrome is associated with severe acute pancreatitis. Clin Gastroenterol Hepatol 2009, 7:1247-1251.
40. Wu B.U., Johannes R.S., Sun X., et al. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut 2008, 57:1698-1703.
41. Wu B.U., Bakker O.J., Papachristou G.I., et al. Blood urea nitrogen in the early assessment of acute pancreatitis: an international validation study. Arch Intern Med 2011, 171:669-676.
42. Hosten A.O. BUN and creatinine. Clinical methods: the history, physical, and laboratory examinations 1990, 874-878. Butterworths, Boston. 3rd ed. H.K. Walker, W.D. Hall, J.W. Hurst (Eds.).
43. Dickerson R.N., Vehe K.L., Mullen J.L., et al. Resting energy expenditure in patients with pancreatitis. Crit Care Med 1991, 19:484-490.
44. Vege S.S., Gardner T.B., Chari S.T., et al. Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include "moderately severe acute pancreatitis". Am J Gastroenterol 2009, 104:710-715.
45. De Waele J.J., Leppaniemi A.K. Intra-abdominal hypertension in acute pancreatitis. World J Surg 2009, 33:1128-1133.
46. Whitcomb D.C., Muddana V., Langmead C.J., et al. Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany. Am J Gastroenterol 2010, 105:2287-2292.